INTERACTION OF CELLULAR FACTORS WITH INTRAGENIC CIS-ACTING REPRESSIVE SEQUENCES WITHIN THE HIV GENOME

被引:34
作者
OLSEN, HS
COCHRANE, AW
ROSEN, C
机构
[1] ROCHE INST MOLEC BIOL,DEPT GENE REGULAT,ROCHE RES CTR,340 KINGSLAND ST,NUTLEY,NJ 07110
[2] MCGILL UNIV,DEPT MICROBIOL & IMMUNOL,MONTREAL H3A 2B4,QUEBEC,CANADA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/0042-6822(92)90246-L
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Expression of the human immunodeficiency virus (HIV) structural gene products is suppressed in the absence of the Rev protein. The block to expression reflects, in part, nuclear retention of those mRNAs which encode the structural proteins. The presence of intragenic cis-acting repressive sequences (CRS) and inefficient splicing of the primary viral transcript are thought to contribute to nuclear entrapment of viral RNA. To elucidate the mechanism for repression of HIV gene expression, the ability of a 270-bp segment of the pol gene shown previously to repress gene expression to interact with cellular factors was investigated. Incubation of RNA corresponding to the 270-bp CRS element with nuclear extract prepared from human T-cells revealed a strong and specific interaction with several cellular factors. Covalent cross-linking of the RNA-protein complex demonstrated the presence of at least three proteins, the predominant one having a molecular weight of approximately 42 kDa. A monoclonal antibody raised against hnRNP C, a component of the splicing machinery, recognized the CRS-protein complex, suggesting that hnRNP C or a closely related gene product interacts with CRS-containing RNA. Consistent with this conclusion, addition of RNA corresponding to a β-globin intron sequence in the binding reaction completely blocked formation of the CRS-protein complex. These findings raise the possibility that the CRS elements elicit nuclear entrapment of viral RNA through formation of RNA-protein complexes that are not accessible to nuclear export pathways. © 1992.
引用
收藏
页码:709 / 715
页数:7
相关论文
共 50 条
  • [1] REV IS NECESSARY FOR TRANSLATION BUT NOT CYTOPLASMIC ACCUMULATION OF HIV-1 VIF, VPR, AND ENV/VPU-2 RNAS
    ARRIGO, SJ
    CHEN, ISY
    [J]. GENES & DEVELOPMENT, 1991, 5 (05) : 808 - 819
  • [2] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [3] RNA-BINDING PROTEINS AS DEVELOPMENTAL REGULATORS
    BANDZIULIS, RJ
    SWANSON, MS
    DREYFUSS, G
    [J]. GENES & DEVELOPMENT, 1989, 3 (04) : 431 - 437
  • [4] A NUCLEAR TRANSLATIONAL BLOCK IMPOSED BY THE HIV-1 U3 REGION IS RELIEVED BY THE TAT-TAR INTERACTION
    BRADDOCK, M
    THORBURN, AM
    CHAMBERS, A
    ELLIOTT, GD
    ANDERSON, GJ
    KINGSMAN, AJ
    KINGSMAN, SM
    [J]. CELL, 1990, 62 (06) : 1123 - 1133
  • [5] PRIMARY STRUCTURES OF THE HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2-PROTEIN, B1-PROTEIN, AND C2-PROTEIN - A DIVERSITY OF RNA-BINDING PROTEINS IS GENERATED BY SMALL PEPTIDE INSERTS
    BURD, CG
    SWANSON, MS
    GORLACH, M
    DREYFUSS, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) : 9788 - 9792
  • [6] REGULATION BY HIV REV DEPENDS UPON RECOGNITION OF SPLICE SITES
    CHANG, DD
    SHARP, PA
    [J]. CELL, 1989, 59 (05) : 789 - 795
  • [7] HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS - ROLE IN RNA SPLICING
    CHOI, YD
    GRABOWSKI, PJ
    SHARP, PA
    DREYFUSS, G
    [J]. SCIENCE, 1986, 231 (4745) : 1534 - 1539
  • [8] IDENTIFICATION AND CHARACTERIZATION OF INTRAGENIC SEQUENCES WHICH REPRESS HUMAN-IMMUNODEFICIENCY-VIRUS STRUCTURAL GENE-EXPRESSION
    COCHRANE, AW
    JONES, KS
    BEIDAS, S
    DILLON, PJ
    SKALKA, AM
    ROSEN, CA
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (10) : 5305 - 5313
  • [9] SPECIFIC INTERACTION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS REV PROTEIN WITH A STRUCTURED REGION IN THE ENV MESSENGER-RNA
    COCHRANE, AW
    CHEN, CH
    ROSEN, CA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (03) : 1198 - 1202
  • [10] CULLEN BR, 1987, METHOD ENZYMOL, V152, P684